Collections: Health Policy and Services Research / Subjects: United States - Digital Collections - National Library of Medicine Search Results

Start Over Collections Health Policy and Services Research ✖ Subjects United States ✖

2931. Preventing drug diversion: disposal of controlled substances in home hospice settings : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, April 2020
Subject(s):: Controlled Substances
Drug and Narcotic Control -- organization & administration
Hospice Care
Prescription Drug Diversion
United States

2932. Anesthesia services: differences between private and Medicare payments likely due to providers' strong negotiating position : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, October 2020
Subject(s):: Anesthesia -- economics
Medicare -- economics
United States
Centers for Medicare & Medicaid Services (U.S.)

2933. Science and tech spotlight: COVID-19 vaccine development

Publication:: [Washington, DC] : United States Government Accountability Office, May 2020
Subject(s):: COVID-19 Vaccines -- therapeutic use
Drug Development
United States

2934. Science and tech spotlight: COVID-19 testing

Publication:: [Washington, DC] : United States Government Accountability Office, May 2020
Subject(s):: COVID-19 Testing -- methods
United States
United States. Food and Drug Administration

2935. Policy for testing of alcohol (ethanol) and isopropyl alcohol for methanol, including during the public health emergency (COVID-19)

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
Subject(s):: 2-Propanol
Drug Compounding
Ethanol
Methanol
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2936. Protecting participants in bioequivalence studies for abbreviated new drug applications during the COVID-19 public health emergency

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
Subject(s):: Drug Approval
Patient Safety
Therapeutic Equivalency
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2937. COVID-19: potency assay considerations for monoclonal antibodies and other therapeutic proteins targeting SARS-CoV-2 infectivity

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
Subject(s):: Antibodies, Monoclonal
COVID-19 -- drug therapy
Enzyme-Linked Immunosorbent Assay
SARS-CoV-2
Viral Plaque Assay
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2938. Requests for feedback and meetings for medical device submissions: the Q-Submission Program : guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, January 6, 2021
Subject(s):: Device Approval
Formative Feedback
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2939. Safer technologies program for medical devices: guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, January 6, 2021
Subject(s):: Device Approval
Equipment Safety
Voluntary Programs
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2940. Mouse embryo assay for assisted reproduction technology devices: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, January 5, 2021
Subject(s):: Biological Assay
Device Approval
Embryo, Mammalian
Mice
Reproductive Techniques, Assisted
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

« Previous
Next »
1
2
…
290
291
292
293
294
295
296
297
298
…
543
544